Article Text
Declarations of Interest
P27 Deprivation in the copd salford lung study (sls) is associated with higher healthcare costs but does not moderate the main outcomes
Abstract
R Jones: Personal fees from AstraZeneca, Boehringer-Ingelheim, Chiesi, Cipla, GSK, Novartis and Pfizer
A Nicholls: GSK employee, holds GSK shares
D Browning: GSK employee
N Diar Bakerly: Employing organisation provided IT support to automated data collection method for the SLS COPD and Asthma trials. NDB received financial support to attend meeting in the form of non-restricting educational grants from GSK, Novartis, Astra Zeneca and BI
A Woodcock: Honoraria (GSK, Chiesi and Zambon)
J Vestbo: Honoraria from GSK, AstraZeneca, BI, Chiesi and Novartis for consulting/presenting
D Leather: GSK employee, holds GSK shares